Rare prostate cancer subtypes demand better detection and dedicated trials
A new review finds that rare prostate cancer histologies, which make up less than 5% of cases, are aggressive, often ...
A new review finds that rare prostate cancer histologies, which make up less than 5% of cases, are aggressive, often ...
A retrospective cohort of 144 men in Côte d'Ivoire found that 20.8 percent of patients with metastatic castration-resistant prostate cancer ...
A genetic variant in the RNA-modifying gene WDR4 has been associated with prostate cancer susceptibility in a two-stage genetic association ...
A retrospective analysis of 194 patients found that PSMA-PET/CT identified 91% of clinically significant prostate cancers and had a high ...
A prospective observational study linked circulating tumor DNA fraction and copy-number burden with progression and survival in 78 patients receiving ...
The multicenter StereoBed trial will randomize 284 patients to compare five-fraction stereotactic radiotherapy with standard schedules after prostatectomy, with two-year ...
A free October 1, 2026 webinar will discuss four Alliance clinical-trial findings from the 2026 ASCO Annual Meeting in breast, ...
A prospective EPIC-based study found blood-protein associations with prostate cancer more than 15 years before diagnosis, including markers linked to ...
In preclinical castration-resistant prostate cancer models, combining B7-H3 blockade with the MEK inhibitor trametinib overcame compensatory immune suppression and structural ...
A TCGA-based prostate cancer study developed a coagulation-associated lncRNA prognostic signature, found distinct immune-related features in high-risk patients, and showed ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine